Skip to content
ppharmaranks
Menu

Mirdametinib: uses, dosing, side effects & brands

Mirdametinib is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Capsule · Tablet
Sold as
Gomekli
Prescription?
Prescription only
Generic available?
Not in our catalog

Every mirdametinib product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Gomekli.

What mirdametinib pills look like

Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.

Mirdametinib pill imprints
ImprintStrengthColourShape
MIR;1mg1 mggreencapsule
MIR;2mg2 mgwhite, bluecapsule
S1 mgwhiteoval

Can you crush or split mirdametinib?

At least one mirdametinibproduct is labelled to be swallowed whole — crushing an extended-release tablet releases the whole day’s dose at once. Which applies depends on the form you were given.

What each mirdametinib label says about crushing, splitting and chewing

What people report to the FDA about mirdametinib

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 19 reports naming mirdametinib, and the FDA flagged 95% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • diarrhoea6 reports
  • dehydration5 reports
  • dermatitis acneiform4 reports
  • fatigue4 reports
  • nausea4 reports
  • abdominal discomfort3 reports
  • acne3 reports
  • blindness unilateral3 reports

Read these as a signal, not a rate. A report does not mean mirdametinib caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.

Related calculators

Frequently asked questions

Can you take mirdametinib with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run mirdametinib against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does mirdametinib come in?

Across the brands we track, mirdametinib is currently marketed as capsule and tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic mirdametinib?

We do not currently list a generic-labelled mirdametinib product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Mirdametinib: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/mirdametinib
MLA
“Mirdametinib: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/mirdametinib.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for mirdametinib on DailyMed (NIH) ↗.